ArticleBMC complementary medicine and therapies2023

A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma.

Xue Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.